Researchers at Stanford have developed synthetic derivatives of a natural product, azapodophyllotoxin (AZP), that exhibit remarkable anticancer activities.
Researchers at Stanford, funded in part by the Chan Zuckerberg Biohub, have developed a method for determining infant susceptibility to severe dengue disease through measurement of maternal anti-dengue IgG.
Researchers in the Fuller group have designed a platform and method for measuring the thickness profiles of dynamic thin liquid films at high frequencies. The key steps in the new method called as dynamic hyperspectral interferometry are as follows.
Researchers at Stanford, funded in part by the Chan Zuckerberg Biohub, have developed PMD (Protect, Modify, Deprotect), an immunofocusing strategy that can be used in vaccine development for the generation of antibodies targeting a specific epitope.
Researchers at Stanford, funded in part by the Chan Zuckerberg Biohub, have generated a crystal structure for human PD-1 in complex with one of its ligands, PD-L2, for use in small molecule inhibitor design.
Researchers at Stanford, funded in part by the Chan Zuckerberg Biohub, have generated a method for performing multi-parametric and high-throughput single cell genomic and phenotypic analyses.
The Salisbury lab has developed a dexterous robotic hand with active fingertip surfaces for grasping and manipulation. Spherical or oblate graspers exhibit two coupled degrees of freedom, steering and rolling, allowing objects to easily be manipulated by the wheels.
Researchers at Stanford have developed a new catalog of compact transcription effector domains and fused them onto DNA binding domains to engineer synthetic transcription factors.
Stanford researchers at Prof. Safavi-Naeini's laboratory have developed a high quality, scalable processor architecture using small, phononic crystal resonators for read-out and long-lived storage in superconducting circuit quantum computing.
Stanford researchers have identified a biomarker on cartilage precursor cells that can predict which cells will develop into inflammation-resistant and functionally appropriate tissue for autologous transplants to treat osteoarthritis.